Deal involves two top Boston academic medical centers.
Siemens Avanto scanner wrecked as VA suffered 4-5 ft. of flooding.
Meanwhile, KLAS surveys health care providers on Intelerad's workflow management software.
Faster, cheaper, safer?
Letters from the online editors - November
Optima MR360 and Brivo MR355 among the fastest-selling MRIs in GE's history.
U.S. Commercial Service report explores opportunities for U.S. exporters.
GPOs and manufacturers don't see eye-to-eye on UDI timeline.
An alarming problem.
Investments in the med equipment sector drop 37 percent from last quarter.
Closes deal on Kiwi firm Emendo.
Siemens says new offering could improve patient and staff satisfaction.
Celebrate RTs Nov.4-10.
Useful, but not diagnostic.
The two societies join six others in arguing for a crackdown on self-referral "loophole."
Final payment rule includes expanded MPPR.
M6 Series receives 510(k) clearance.
Eagerly awaited report still shows health care is hiring.
Getting a foothold in the value market.
Next-gen systems debut at ASTRO.
Some 200 patients are transferred to other hospitals.
Longer-term studies needed.
Two-thirds of patients don't realize it's not a cure.
Rinse and repeat.
Battening down the hatches.
Historic storm closes in on the city.
McKesson expands surgical business.
Prototype has already been created in the Netherlands.
Maybe not, an industry-funded report says.
Medicare data affirms medical imaging utilization's slowing growth.
And $5.1 billion in five years.
Amyvid could be on its way to the Continent.
Brookhaven National Laboratory is honored for its role in synthesizing common PET agent.
ExAblate cleared to treat pain from bone mets.
VuComp's second-gen digital mammo CAD
Advisa DR MRI SureScan now available in Japan.
Chirag Patel agrees to pay back $80K.
ECRI Institute gives CT scanner purchasing advice while explaining that 128-slice units are in demand.
Delivery set for 2014.
Companies to offer imaging systems, OR lights, and suite design.
The average age of MRI scanners has gone up.
Millions of years of healthy life lost to cancer, every year.
Survey: Docs prefer aggressive treatments for low-risk prostate cancer
Kirtsaeng v. John Wiley & Sons Inc. could affect dealers that import equipment.
Market research firm predicts $1 billion growth over the next half-decade.
Euan S. Thomson steps down.
Joshua Levine says new tech is critical for company's revenue growth.
Pacific island might be next in line after New York and California.
Construction firm gets Saudi proton contract.